Cargando…

Safety and Efficacy of Eculizumab Therapy in Multiple Sclerosis: A Case Series

(1) Background: Complement system activation has been proposed as one of the different factors that contribute to Multiple Sclerosis (MS) pathogenesis. In this study, we aimed to describe the potential effects of eculizumab, an anticomplement therapy, on MS disease activity in a cohort of relapsing–...

Descripción completa

Detalles Bibliográficos
Autores principales:	Allinovi, Marco, Bellinvia, Angelo, Pesce, Francesco, Milan Manani, Sabrina, Razzolini, Lorenzo, Brezzi, Brigida, Protopapa, Paolo, Mantero, Vittorio, Caroti, Leonardo, Cirami, Calogero Lino, Amato, Maria Pia, Del Vecchio, Lucia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533854/ https://www.ncbi.nlm.nih.gov/pubmed/34679405 http://dx.doi.org/10.3390/brainsci11101341

Ejemplares similares

Thrombotic microangiopathy induced by interferon beta in patients with multiple sclerosis: three cases treated with eculizumab
por: Allinovi, Marco, et al.
Publicado: (2017)

Broad spectrum of interferon-related nephropathies-glomerulonephritis, systemic lupus erythematosus-like syndrome and thrombotic microangiopathy: A case report and review of literature
por: Gianassi, Iacopo, et al.
Publicado: (2019)

Hemolytic uremic syndrome and kidney transplantation in uncontrolled donation after circulatory death (DCD): A two-case report
por: Caroti, Leonardo, et al.
Publicado: (2021)

Long-term Use of Eculizumab in Kidney Transplant Recipients
por: Milan Manani, Sabrina, et al.
Publicado: (2018)

De novo collapsing glomerulopathy after kidney transplantation: Description of two cases
por: Cutruzzulà, Roberta, et al.
Publicado: (2023)

Cognitive Issues in Pediatric Multiple Sclerosis
por: Portaccio, Emilio, et al.
Publicado: (2021)

Cerebrospinal Fluid IgM and Oligoclonal IgG Bands in Multiple Sclerosis: A Meta-Analysis of Prevalence and Prognosis
por: Fonderico, Mattia, et al.
Publicado: (2021)

Posttransplant outcome of atypical haemolytic uraemic syndrome in a patient with thrombomodulin mutation: a case without recurrence
por: Caroti, Leonardo, et al.
Publicado: (2015)

Hypogammaglobulinemia is associated with reduced antibody response after anti-SARS-CoV-2 vaccination in MS patients treated with antiCD20 therapies
por: Bellinvia, Angelo, et al.
Publicado: (2022)

The Brain-Derived Neurotrophic Factor Val66Met Polymorphism Can Protect Against Cognitive Impairment in Multiple Sclerosis
por: Portaccio, Emilio, et al.
Publicado: (2021)

Cognitive impairment in multiple sclerosis: An exploratory analysis of environmental and lifestyle risk factors
por: Amato, Maria Pia, et al.
Publicado: (2019)

Correction: Cognitive impairment in multiple sclerosis: An exploratory analysis of environmental and lifestyle risk factors
por: Amato, Maria Pia, et al.
Publicado: (2019)

The Role of Rituximab in Primary Focal Segmental Glomerular Sclerosis of the Adult
por: Tedesco, Martina, et al.
Publicado: (2022)

Pre-Dialysis B-Line Quantification at Lung Ultrasound Is a Useful Method for Evaluating the Dry Weight and Predicting the Risk of Intradialytic Hypotension
por: Allinovi, Marco, et al.
Publicado: (2022)

Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab
por: Wijnsma, Kioa Lente, et al.
Publicado: (2019)

Eculizumab Dosing in Infants
por: Kobrzynski, M., et al.
Publicado: (2018)

Novel Biomarkers for Early Detection of Acute Kidney Injury and Prediction of Long-Term Kidney Function Decline after Partial Nephrectomy
por: Allinovi, Marco, et al.
Publicado: (2023)

A multidisciplinary case report of multiple myeloma with renal and cardiac involvement: a look beyond amyloidosis
por: Innocenti, Samantha, et al.
Publicado: (2022)

Exercise Prescription in Renal Transplant Recipients: From Sports Medicine Toward Multidisciplinary Aspects: A Pilot Study
por: Orlandi, Goffredo, et al.
Publicado: (2020)

The utility of remote patient management in peritoneal dialysis
por: Yeter, Haci Hasan, et al.
Publicado: (2021)

Eculizumab in Early-Stage Pregnancy
por: Morales, Enrique, et al.
Publicado: (2020)

Clinical Application of 2017 McDonald Diagnostic Criteria for Multiple Sclerosis
por: Mantero, Vittorio, et al.
Publicado: (2018)

Neutrophil gelatinase-associated lipocalin dipstick test in peritoneal dialysis patients with peritonitis
por: Milan Manani, Sabrina, et al.
Publicado: (2021)

Thrombotic Microangiopathy Secondary to Systemic Sclerosis with Severe Complement Activation Not Responsive to Eculizumab: A Case Report
por: Nakamura, Masahiko, et al.
Publicado: (2022)

Eculizumab in recalcitrant antiphospholipid antibody syndrome
por: Zapantis, Ekaterini, et al.
Publicado: (2014)

Treating C3 glomerulopathy with eculizumab
por: Welte, Thomas, et al.
Publicado: (2018)

Eculizumab in chemotherapy-induced thrombotic microangiopathy
por: Schulte-Kemna, Lena, et al.
Publicado: (2020)

Eculizumab: COVID-19: case report
Publicado: (2021)

Eculizumab for refractory thrombosis in antiphospholipid syndrome
por: Hussain, Habiba, et al.
Publicado: (2022)

PB2051: POPULATION PHARMACOKINETIC/PHARMACODYNAMIC/EFFICACY MODELING OF SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) AND REFERENCE ECULIZUMAB
por: Lee, Hyuna, et al.
Publicado: (2023)

MxA mRNA Quantification and Disability Progression in Interferon Beta-Treated Multiple Sclerosis Patients
por: Serana, Federico, et al.
Publicado: (2014)

COVID‐19 in dimethyl fumarate‐treated patients with multiple sclerosis
por: Mantero, Vittorio, et al.
Publicado: (2020)

Placental disposition of eculizumab, C5 and C5‐eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria
por: Eliesen, Gaby A.M., et al.
Publicado: (2020)

Rituximab in relapsing and de novo MPO ANCA-associated vasculitis with severe renal involvement: a case series
por: Caroti, L., et al.
Publicado: (2019)

Robotic Versus Open Kidney Transplantation from Deceased Donors: A Prospective Observational Study()
por: Campi, Riccardo, et al.
Publicado: (2022)

Rituximab Therapy for Adults with Nephrotic Syndromes: Standard Schedules or B Cell-Targeted Therapy?
por: Del Vecchio, Lucia, et al.
Publicado: (2021)

Assessing the susceptibility to acute respiratory illness COVID-19-related in a cohort of multiple sclerosis patients
por: Mantero, Vittorio, et al.
Publicado: (2020)

The pathophysiology of paroxysmal nocturnal hemoglobinuria and treatment with eculizumab
por: Kelly, Richard, et al.
Publicado: (2009)

The effects of Eculizumab on the pathology of malignant atrophic papulosis
por: Magro, Cynthia M, et al.
Publicado: (2013)

Treatment of atypical uraemic syndrome in the era of eculizumab
por: Fremeaux-Bacchi, Veronique
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_418vqa9h0np4oqj4qbmtc2mc0q